Astrivax is a Belgium-based biotechnology company that develops and commercializes vaccines for the treatment of infectious diseases.
Business Model:
Revenue: $250k
Employees: 2-10
Address: Ambachtenlaan 1
City: Heverlee
State: flemish brabant
Zip: 3001
Country: BE
Astrivax is a Belgium-based biotechnology company that develops and commercializes vaccines for the treatment of infectious diseases.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 8/2022 | Seed | $29.9M |
V-Bio Ventures Fund+ Thuja Capital Ackermans & van Haaren Mérieux Equity Partners BNP Paribas Fortis Private Equity |
8/2022 | Seed Round | 8 | $30M |
Ackermans &a; van Haaren BNP Paribas Fortis Flanders Future Techfund Fund+ Gemma Frisius Fund Mérieux Equity Partners Thuja Capital V-Bio Ventures Ackermans &a; van Haaren BNP Paribas Fortis Flanders Future Techfund Fund+ Gemma Frisius Fund Mérieux Equity Partners Thuja Capital V-Bio Ventures |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|